47.13

4.21% 1.96

Vera Therapeutics Inc (VERA)

Overview News Price History Option Chain Financials Discussions Forecast

Vera Therapeutics Inc stock is traded at $47.13, with a volume of 305.82K. It is up +4.21% in the last 24 hours and up +15.25% over the past month. Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Previous Close:

$45.17

Open:

$45.24

24h Volume:

305.82K

Relative Volume:

0.47

Market Cap:

$2.88B

Revenue:

Net Income/Loss:

$-94.30M

P/E Ratio:

-14.03

EPS:

-3.36

Net Cash Flow:

$-99.72M

1W Performance:

+9.54%

1M Performance:

+15.25%

6M Performance:

+8.36%

1Y Performance:

+347.43%

1-Day Range:

$44.94

$47.20

1-Week Range:

$40.27

$47.16

52-Week Range:

$9.88

$50.78

Vera Therapeutics Inc Stock (VERA) Company Profile

Name

Vera Therapeutics Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

650-770-0077

Address

8000 MARINA BOULEVARD, SUITE 120, BRISBANE

Employee

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

VERA's Discussions on Twitter

Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-25-24	Initiated	Oppenheimer	Outperform
Jan-08-24	Initiated	Cantor Fitzgerald	Overweight
Dec-18-23	Initiated	Raymond James	Outperform
Nov-10-23	Upgrade	Jefferies	Hold → Buy
Aug-16-23	Initiated	Guggenheim	Buy
Jan-04-23	Downgrade	Jefferies	Buy → Hold
Jan-04-23	Downgrade	Wedbush	Outperform → Neutral
Jul-12-22	Initiated	JP Morgan	Overweight
May-02-22	Initiated	H.C. Wainwright	Buy
Apr-19-22	Initiated	Wedbush	Outperform

View All

Vera Therapeutics Inc Stock (VERA) Latest News

11:35 AM

Vera Therapeutics (NASDAQ:VERA) Given New $75.00 Price Target at JPMorgan Chase & Co. - MarketBeat

11:35 AM

12:22 PM

Trading (VERA) With Integrated Risk Controls - Stock Traders Daily

12:22 PM

Nov 01, 2024

Vera Therapeutics (NASDAQ:VERA) Shares Up 7.3%Here's Why - MarketBeat

Nov 01, 2024

Oct 31, 2024

Vera Therapeutics announces proposed public offering of class A common stock - MSN

Oct 31, 2024

Oct 30, 2024

Vera Therapeutics director Beth Seidenberg sells shares for $720,493 - Investing.com India

Oct 30, 2024

Vera Therapeutics director Beth Seidenberg sells shares for $720,493 By Investing.com - Investing.com Canada

Oct 30, 2024

Vera Therapeutics (NASDAQ:VERA) Sees Large Volume IncreaseHere's What Happened - MarketBeat

Oct 30, 2024

Vera Therapeutics (NASDAQ:VERA) PT Raised to $64.00 at Guggenheim - Defense World

Oct 30, 2024

Oct 29, 2024

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock - GlobeNewswire

Oct 29, 2024

Vera Therapeutics (NASDAQ:VERA) Shares Gap DownHere's Why - MarketBeat

Oct 29, 2024

Vera Therapeutics price target raised to $64 from $56 at Guggenheim - Yahoo Finance

Oct 29, 2024

SEC Form 424B5 filed by Vera Therapeutics Inc. - Quantisnow

Oct 29, 2024

Oct 28, 2024

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock - GlobeNewswire

Oct 28, 2024

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock - GlobeNewswire Inc.

Oct 28, 2024

Vera Therapeutics (NASDAQ:VERA) Price Target Raised to $64.00 - MarketBeat

Oct 28, 2024

Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients At Almost Two Years - AOL

Oct 28, 2024

Vera Therapeutics (NASDAQ:VERA) Shares Gap UpHere's What Happened - MarketBeat

Oct 28, 2024

Vera Therapeutics Shares Climb 14% on Positive Results in Kidney Disease Study - MarketWatch

Oct 28, 2024

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday - Benzinga

Oct 28, 2024

Vera reports long-term atacicept data at Kidney Week 2024 - The Pharma Letter

Oct 28, 2024

Oct 27, 2024

VERAVera Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 27, 2024

Oct 26, 2024

Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 - The Manila Times

Oct 26, 2024

Vera Therapeutics Announces 96-week eGFR Stabilization in - GlobeNewswire

Oct 26, 2024

Oct 25, 2024

Marshall Fordyce Sells 19,375 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock - MarketBeat

Oct 25, 2024

Vera Therapeutics CEO sells shares worth $782,610 By Investing.com - Investing.com South Africa

Oct 25, 2024

Eastern Bank Purchases Shares of 56,050 Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat

Oct 23, 2024

Oct 21, 2024

S&P 500 Financials [Sector] (SRFI) QuotePress Release - The Globe and Mail

Oct 21, 2024

Oct 16, 2024

Polycythemia Vera Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Clinical Trials | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeutics, Ascentage - The Globe and Mail

Oct 16, 2024

Vera Therapeutics (NASDAQ:VERA) Coverage Initiated by Analysts at Scotiabank - MarketBeat

Oct 16, 2024

A year in review: Vera Therapeutics Inc (VERA)’s performance in the last year - US Post News

Oct 16, 2024

Oct 14, 2024

The Potential Rise in the Price of Vera Therapeutics Inc (VERA) following insiders activity - Knox Daily

Oct 14, 2024

Oct 13, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 13, 2024

Oct 12, 2024

Vera Therapeutics CEO sells shares worth over $597k - Investing.com India

Oct 12, 2024

Vera Therapeutics CEO sells shares worth over $597k By Investing.com - Investing.com South Africa

Oct 12, 2024

Oct 11, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells $597,500.00 in Stock - MarketBeat

Oct 11, 2024

Oct 10, 2024

Nonfat Dry Milk (DFU25) Quote - The Globe and Mail

Oct 10, 2024

Oct 08, 2024